The StartUPDATES is a member feature of MedCitizens, a community of MedCity News startups. Submit here and join.
Bright.md announced the addition of a low back pain module to its SmartExam telehealth solution to help patients get comprehensive treatment for low back pain, a condition 80 percent of adults will experience in their lifetime.
“Low back pain is one of the most common reasons that people seek care — and miss work,” said Dr. Eric Norris, Medical Director of Express Care Clinics at Providence St. Joseph Health in Portland, Oregon. “This new SmartExam module is simple, on point and will allow patients to get safe, evidence-based treatment from a provider they trust without making what can be a painful trip to a medical office.”
SmartExam acts as a virtual physician’s assistant, collecting health information and integrating it back into the electronic health record. The low back pain module was made possible with the addition of order and referral management (ORM) capabilities within SmartExam. Patients with low back pain log onto SmartExam with a smartphone, computer or tablet, answer questions about their pain and symptoms and receive a treatment plan from their provider. Treatment can include a referral to a physical or massage therapist or another practitioner for further consultation.
“With referrals, healthcare providers are able to safely and effectively diagnose and treat patients and help them along their care journey within the system,” said Dr. Ray Costantini, CEO and co-founder of Bright.md. “The seamless care experience leads to better patient outcomes for lower back pain and other health issues, and helps systems attract and retain patients.”
Philadelphia-based mental health technology company NeuroFlow has hired Andrew Kahn as senior sales manager.
Health IT startup Verato has raised $10 million in a Series C round. The company has zeroed in on solving the problem of duplicate medical records. They can lead to claims denials, increase patient safety concerns and boost healthcare costs due to redundant testing and procedures. Investors include Bessemer Venture Partners, Columbia Capital, Blue Heron Capital, and California Health Care Foundation.
Photo: akindo, Getty Images